Join to View Full Profile
3601 5th AveSte 2BPittsburgh, PA 15213
Phone+1 412-647-6700
Fax+1 412-692-4313
Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an early-career physician-scientist dedicated to unraveling the immunopathology of Sjögren's disease (SjD), a common systemic autoimmune disorder with no FDA-approved disease-modifying treatments. My research integrates small animal models with patient cohort studies to uncover novel insights into SjD. I aim to identify new therapeutic targets and implement resulting treatments to reduce the morbidity and mortality associated with Sjögrens.
Education & Training
University of Pittsburgh School of MedicineClass of 2019
Certifications & Licensure
PA State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- A systematic review of clinical trial designs and outcome measures in Sjögren's disease randomized trials.Maxime Beydon, Yann Nguyen, Rachael Gordon, Nathan Foulquier, Coralie Bouillot
The Journal of Rheumatology. 2025-04-01 - 3 citationsNADPH oxidase in B cells and macrophages protects against murine lupus by regulation of TLR7.Rachael A Gordon, Haylee A Cosgrove, Anthony Marinov, Sebastien Gingras, Jeremy S Tilstra
JCI Insight. 2024-07-23 - 1 citationsIdentification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group.Yann Nguyen, Maxime Beydon, Nathan Foulquier, Rachael Gordon, Coralie Bouillot
Seminars in Arthritis and Rheumatism. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
